dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet

RxCUI
1925498
RxNorm name
dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet
Display name
Dapagliflozin/sAXagliptin (Oral Pill)
Full name
dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet
Term type
SCD
Status
Active
Strength
10-5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-27 19:32:44

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072017
Active start
072017
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
dapagliflozin propanediol10 MG / 1 EACHdapagliflozindapagliflozin
saxagliptin hydrochloride5 MG / 1 EACHsaxagliptinsaxagliptin

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
dapagliflozin1488564
saxagliptin857974

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet1NAMES
RxNorm Namedapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet1NAMES
RxNorm Synonymdapagliflozin 10 MG (as dapagliflozin propanediol 12.3 MG) / saxagliptin 5 MG (as saxagliptin HCl 5.95 MG) Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID1cfa51fd-8406-404c-b2a8-0fc1068675fb1CODES
RxCUI19254981CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
72205-438-0172205-438DAPAGLIFLOZIN AND SAXAGLIPTIN DAPAGLIFLOZIN AND SAXAGLIPTINNovadoz Pharmaceuticals LLCANDA211533
72205-438-0272205-438DAPAGLIFLOZIN AND SAXAGLIPTIN DAPAGLIFLOZIN AND SAXAGLIPTINNovadoz Pharmaceuticals LLCANDA211533

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA21153372205-438DAPAGLIFLOZIN AND SAXAGLIPTIN DAPAGLIFLOZIN AND SAXAGLIPTINANDANovadoz Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
72205043801rxnav_ndcsyes
72205043802rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DAPAGLIFLOZIN AND SAXAGLIPTINDAPAGLIFLOZIN AND SAXAGLIPTINNovadoz Pharmaceuticals LLC1cfa51fd-8406-404c-b2a8-0fc1068675fb2026-04-08Warnings, Adverse reactionsExact identifier
ndc (package): 72205-438-01
ndc (package): 72205-438-02
ndc (product): 72205-438
ndc11 (package): 72205043801
ndc11 (package): 72205043802
rxcui: 1925498

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1cfa51fd-8406-404c-b2a8-0fc1068675fbdapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet [PSN] · dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet [SCD] · dapagliflozin 10 MG (as dapagliflozin propanediol 12.3 MG) / saxagliptin 5 MG (as saxagliptin HCl 5.95 MG) Oral Tablet [SY]31These highlights do not include all the information needed to use DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS. DAPAGLIFLOZIN AND SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 201720260408

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
1cfa51fd-8406-404c-b2a8-0fc1068675fbThese highlights do not include all the information needed to use DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN AND SAXAGLIPTIN TABLETS. DAPAGLIFLOZIN AND SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2017Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260408

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA10BDCombinations of oral blood glucose lowering drugsATC1-4dapagliflozin / saxagliptin
ATCA10BHDipeptidyl peptidase 4 (DPP-4) inhibitorsATC1-4saxagliptin
ATCA10BKSodium-glucose co-transporter 2 (SGLT2) inhibitorsATC1-4dapagliflozin
FDASPLN0000187059Sodium-Glucose Cotransporter 2 InhibitorEPChas_epcdapagliflozin
FDASPLN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTD000218AdamantaneCHEMhas_ingredientsaxagliptin
MEDRTD001559Benzhydryl CompoundsCHEMhas_ingredientdapagliflozin
MEDRTD004151DipeptidesCHEMhas_ingredientsaxagliptin
MEDRTD005960GlucosidesCHEMhas_ingredientdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatsaxagliptin
MEDRTD004342Drug HypersensitivityDISEASEci_withsaxagliptin
MEDRTD006333Heart FailureDISEASEmay_treatdapagliflozin
MEDRTN0000175912Dipeptidyl Peptidase 4 InhibitorsMOAhas_moasaxagliptin
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTN0000008644Decreased Glucagon SecretionPEhas_pesaxagliptin
MEDRTN0000175650Decreased Sympathetic ActivityPEhas_pedapagliflozin
MEDRTN0000009360Increased Insulin SecretionPEhas_pesaxagliptin
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH10 MG / 5 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA211533
CODESSNOMEDCT1303122001
CODESVUID4037068
NAMESPrescribable Synonymdapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet
NAMESTallman Synonymdapagliflozin 10 MG (as dapagliflozin propanediol 12.3 MG) / sAXagliptin 5 MG (as sAXagliptin HCl 5.95 MG) Oral Tablet
NAMESTallman Synonymdapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File